← back to search

Peter A.S. Johnstone

Moffitt Cancer Center · US
Area of research
Pulmonary and Respiratory Medicine · Radiation
Research interest
Research interests include Advanced Radiotherapy Techniques, Prostate Cancer Diagnosis and Treatment, Prostate Cancer Treatment and Research, and Genital Health and Disease.
h-index
42
citations
6,740
works
250
NIH funding
primary concept
email

Recent publications

Neoadjuvant prostate artery embolization prior to prostate radiation therapy: A single institution experience on the durability of clinical urinary improvement after radiation
Clinical and Translational Radiation Oncology 2025cited by 2position: contributordoi
Prostate Artery Embolization in the Setting of Prostate Cancer: Review and Opinion.
2025cited by 1position: contributordoi
Hypofractionated accelerated radiation dose-painting (HARD) improves outcomes in unresected soft-tissue sarcoma.
2025cited by 0position: contributordoi
Penile Cancer: EAU-ASCO Collaborative Guidelines Update Q and A.
2024cited by 21position: contributordoi
Multiplex Immunofluorescence Captures Progressive Immune Exhaustion with Advancing Penile Squamous Cell Cancer Stage.
2024cited by 7position: contributordoi
The Role of Radiation, Immunotherapy, and Chemotherapy in the Management of Locally Advanced or Metastatic Cutaneous Malignancies.
2024cited by 3position: contributordoi
International case series of metastasis to penis.
2024cited by 3position: contributordoi
Clinical Outcomes of Prostate SBRT Using Non-adaptive MR-Guided Radiotherapy.
2024cited by 1position: contributordoi
European Association of Urology-American Society of Clinical Oncology Collaborative Guideline on Penile Cancer: 2023 Update
European Urology 2023cited by 164position: middledoi
Management of Lymph Node–positive Penile Cancer: A Systematic Review
European Urology 2023cited by 50position: middledoi
Stereotactic body radiation therapy versus conventional external beam radiotherapy for spinal metastases: A systematic review and meta-analysis of randomized controlled trials
Radiotherapy and Oncology 2023cited by 35position: middledoi
Penile Cancer: EAU-ASCO Collaborative Guidelines Update Q and A
JCO Oncology Practice 2023cited by 32position: middledoi
The Prognostic Role of Human Papillomavirus and p16 Status in Penile Squamous Cell Carcinoma-A Systematic Review.
2023cited by 18position: contributordoi
Systematic Review and Meta-analysis of Minimally Invasive Procedures for Surgical Inguinal Nodal Staging in Penile Carcinoma
European Urology Focus 2023cited by 14position: middledoi
An Assessment of the Penile Squamous Cell Carcinoma Surfaceome for Biomarker and Therapeutic Target Discovery.
2023cited by 1position: contributordoi
Magnetic resonance guidance is enough for prostate cancer: save adaptation for the patients it will really help.
2023cited by 0position: contributordoi
Complete Response of Primary Penile Tumor With Induction Paclitaxel, Ifosfamide, and Cisplatin (TIP) Chemotherapy
Société Internationale d’Urologie Journal 2023cited by 0position: contributordoi
MRI-Linac Economics II: Rationalizing Schedules.
2022cited by 8position: contributordoi
Changing Radiotherapy Paradigms in Penile Cancer.
2022cited by 7position: contributordoi
Patient-Reported Outcomes in Cancer Patients with HIV.
2022cited by 4position: contributordoi
Novel portable apparatus for outpatient high-dose-rate (HDR) brachytherapy in penile cancer.
2022cited by 1position: contributordoi
Non-Adaptive MR-Guided Radiotherapy for Prostate SBRT: Less Time, Equal Results.
2021cited by 13position: contributordoi
Assessment of MRI-Linac Economics under the RO-APM.
2021cited by 4position: contributordoi
Reply to Vedang Murthy, Abhilash Gavarraju, and Rahul Krishnatry’s Letter to the Editor re: Peter A.S. Johnstone, David Boulware, Rosa Djajadiningrat, et al. Primary Penile Cancer: The Role of Adjuvant Radiation Therapy in the Management of Extranodal Extension in Lymph Nodes. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2018.10.007
European Urology Focus 2021cited by 0position: contributordoi
Patient-reported outcomes: using ESAS to screen for anemia.
2020cited by 5position: contributordoi
Primary Penile Cancer: The Role of Adjuvant Radiation Therapy in the Management of Extranodal Extension in Lymph Nodes
European Urology Focus 2019cited by 32position: contributordoi
Congruence of multiple patient-related outcomes within a single day.
2019cited by 3position: contributordoi
The case for radiotherapy in a Value based environment.
2019cited by 2position: contributordoi
A Comprehensive Definition for Integrative Oncology
JNCI Monographs 2017cited by 276position: middledoi
A genome-based model for adjusting radiotherapy dose (GARD): a retrospective, cohort-based study
The Lancet Oncology 2016cited by 467position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 22 papers (2019–2025)Philippe E. Spiess · Sun Yat-sen University Cancer Center7 papers (2019–2024)Steven A. Eschrich · Moffitt Cancer Center4 papers (2016–2024)Anupam Rishi · University of South Florida3 papers (2022–2025) · 3 papers (2023–2024)James B. Yu · Dartmouth College2 papers (2016–2019)Charles B. Simone · Novartis (United States)2 papers (2023–2024)Nainesh Parikh · Moffitt Cancer Center2 papers (2025–2025)Russell F. Palm · American Society for Radiation Oncology2 papers (2021–2025)Kujtim Latifi · Moffitt Cancer Center2 papers (2025–2025)Filip Ionescu · Moffitt Cancer Center2 papers (2023–2024)Kosj Yamoah · Moffitt Cancer Center2 papers (2024–2025)Jun J. Mao · Second Affiliated Hospital of Anhui Medical University1 papers (2017–2017)Peter Hoskin · Manchester Academic Health Science Centre1 papers (2023–2023)Srinivas Raman · Sunnybrook Health Science Centre1 papers (2023–2023)Jacob G. Scott · Cleveland Clinic1 papers (2016–2016)Lorenzo Cohen · The University of Texas MD Anderson Cancer Center1 papers (2017–2017)Adrian Wai Chan · BC Cancer Agency1 papers (2023–2023)Candice Johnstone · Medical College of Wisconsin1 papers (2023–2023)Anders Berglund · Mayo Clinic in Florida1 papers (2016–2016)